Application 212252

Type
ANDA
Sponsor
NOVITIUM PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ACYCLOVIRACYCLOVIRSUSPENSION;ORAL200MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70954-188acycloviracyclovirNovitium Pharma LLCANDACurrent
70954-188acycloviracyclovirNovitium Pharma LLCANDACurrent
70954-188acycloviracyclovirNovitium Pharma LLCANDACurrent